Search Results for
September 01, 2023
RELEASE: Judge Invested in Big Pharma Shouldn't Try Case on Big Pharma Profiteering
The Revolving Door Project’s Ananya Kalahasti and Will Royce released the following statement regarding the US Chamber of Commerce’s lawsuit regarding the Inflation Reduction Act’s Medicare prescription drug negotiation program, and a financial conflict of interest regarding the judge in the Southern District of Ohio.
August 29, 2023 | The American Prospect
Who’s Running Big Pharma’s Last Stand Against Slightly Fairer Drug Pricing
One year after IRA passage, bad actors try to thwart drug price negotiation, and Biden’s efforts to defend it fall short.
August 01, 2023
GM Exec. To White House: We Can't Be Held To Our Own Standards
Reuters reported Thursday on a recent meeting between the White House Office of Management and Budget officials and General Motors (GM) executive David Strickland. In the meeting, Strickland complained about proposals for updated vehicle emissions rules, which he argued could cost the industry from $100 to $300 billion dollars from 2027, when the rule would take effect, to 2031. Rather than acquiesce to the dire warnings of an economically interested party, the Biden administration did the right thing — it called Strickland’s numbers “pure speculation and inaccurate.”